Guaifenesin 400 Tablet
Product Images NDC 57631-012

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin 400 (NDC 57631-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Invatech Pharma Solutions Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin (Guaifenesin)

This is a description of Guaifenesin tablets USP, each containing 400 mg of the active ingredient Guaifenesin. The tablets are meant for further processing and are bulk shipments. The storage conditions include keeping them at a controlled room temperature of 59° to 86°F and protecting them from light, moisture, and freezing. The tablets are manufactured by Elysium Pharmaceuticals Limited in India and marketed by Invatech Pharma Solutions LLC in New Jersey, USA. A warning advises to keep the tablets out of the reach of children, and a caution specifies that they are intended for manufacturing, processing, or repacking purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.